Biomedical Engineering Reference
In-Depth Information
[149] Sezaki H, Takakura Y, Hashida M. Chemical modification and disposition of pro-
teins and peptides: biopharmaceutical aspects in topics in pharmaceutical sciences.
In: Crommelin DJA, editor. Topics in pharmaceutical sciences. Stuttgart, Germany:
Medpharm Scientific; 1991. p. 47-56.
[150] Aungst BJ, Rogers NJ. Comparison of the effects of various transmucosal absorption
promoters on buccal insulin delivery. Int J Pharm 1989;53:227-35.
[151] Steward A, Bayley DL, Howes C. The effect of enhancers on the buccal absorption of
hybrid (BDBB) alpha-interferon. Int J Pharm 1994;104:145-9.
[152] Mollgaard B. Synergistic effects in percutaneous enhancement. In: Walters KA,
Hadgraft J, editors. Pharmaceutical skin penetration enhancement. New York, NY:
Marcel Dekker; 1993. p. 220-42.
[153] Duchene D, Touchard F, Peppas NA. Pharmaceutical and medical aspects of bioadhe-
sive systems for drug administration. Drug Dev Ind Pharm 1988;14:283-318.
[154] Park K, Robinson JR. Bioadhesive polymers as platforms for oral-controlled drug deliv-
ery: method to study bioadhesion. Int J Pharm 1984;19:107-27.
[155] Park K, Cooper SL, Robinson JR. Bioadhesive hydrogels. In: Peppas NA, editor.
Hydrogels in medicine and pharmacy—properties and applications, vol. 3. Boca Raton,
FL: CRC Press; 1987. p. 151-74.
[156] Pxlate NA, Valuev IL, Sytov GA, Valuev LI. Mucoadhesive polymers with immo-
bilized proteinase inhibitors for oral administration of protein drugs. Biomaterials
2002;23:1673-77.
[157] Rubinstein A, Tirosh B. Mucus gel thickness and turnover in the gastrointestinal tract of
the rat: response to cholinergic stimulus and implication for mucoadhesion. Pharm Res
1994;11:794-9.
[158] Li C, Bhatt PP, Johnston TP. Transmucosal delivery of oxytocin to rabbits using a
mucoadhesive buccal patch. Pharm Dev Technol 1997;2:265-74.
[159] Lehr CM, Bouwstra JA, Kok W, De Boer AG, Tukker JJ, Verhoef JC, et al. Effects of
the mucoadhesive polymer carbophil on the intestinal absorption of a peptide in the rat.
J Pharm Pharmacol 1992;44:402-7.
[160] Sudhakar Y, Kuotsu K, Bandyopadhyay AK. Buccal bioadhesive drug delivery—a
promising option for orally less efficient drugs. J Control Release 2006;114:15-40.
[161] LueBen HL, Lehr CM, Rentel CO, Noach ABJ, Deboer AG, Verhoef JC, et al.
Bioadhesive polymers for the peroral delivery of peptide drugs. J Control Release
1994;29:329-38.
[162] Ponchel G. Formulation of oral mucosal drug delivery systems for the systemic delivery
of bioactive materials. Adv Drug Deliv Rev 1994;13:75-87.
[163] Qiu Y, Zhang G. Development of modified-release solid oral dosage forms. In: Qiu Y,
Chen Y, Zhang GGZ, Liu L, Porter WR, editors. Developing solid oral dosage forms.
San Diego, CA: Elsevier Academic Press; 2009. p. 501-17.
[164] Abdul S, Poddar SS. A flexible technology for modified release of drugs: multi-layered
tablets. J Control Release 2004;97:393-405.
[165] Shen Z, Mitragotri S. Intestinal patches for oral drug delivery. Pharm Res
2002;19:391-5.
[166] Harris D, Robinson JR. Bioadhesive polymers in peptide drug delivery. Biomaterials
1990;11:652-8.
[167] Bruschi ML, Freitas O. Oral Bioadhesive drug delivery systems. Drug Dev Ind Pharm
2005;31:293-310.
[168] Ishida M, Nambu N, Nagai T. Highly viscous gel ointment containing carbopol for
application to the oral mucosa. Chem Pharm Bull 1983;31:4561-4.
Search WWH ::
Custom Search